CN101495478B - 具有抗血栓形成活性的亚氨基-咪唑并-吡啶衍生物 - Google Patents
具有抗血栓形成活性的亚氨基-咪唑并-吡啶衍生物 Download PDFInfo
- Publication number
- CN101495478B CN101495478B CN2007800279925A CN200780027992A CN101495478B CN 101495478 B CN101495478 B CN 101495478B CN 2007800279925 A CN2007800279925 A CN 2007800279925A CN 200780027992 A CN200780027992 A CN 200780027992A CN 101495478 B CN101495478 B CN 101495478B
- Authority
- CN
- China
- Prior art keywords
- compound
- pyridine
- imino
- formula
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 0 *C(c1nc(*)c(*)c(*)c1*)N Chemical compound *C(c1nc(*)c(*)c(*)c1*)N 0.000 description 3
- QNIJHGZEZOTQBX-UHFFFAOYSA-N CC(C)(C)c(cc(cc1C(C)(C)C)C(CN(C=C2N3C=CC(C(C)(F)F)=C2)C3=N)=O)c1O Chemical compound CC(C)(C)c(cc(cc1C(C)(C)C)C(CN(C=C2N3C=CC(C(C)(F)F)=C2)C3=N)=O)c1O QNIJHGZEZOTQBX-UHFFFAOYSA-N 0.000 description 1
- DSWSVIIIXZLNBD-UHFFFAOYSA-N CC(C)(C)c1cc(C(CN(C=C2N3C=CC(C(F)(F)F)=C2)C3=N)=O)cc(C(C)(C)C)c1O Chemical compound CC(C)(C)c1cc(C(CN(C=C2N3C=CC(C(F)(F)F)=C2)C3=N)=O)cc(C(C)(C)C)c1O DSWSVIIIXZLNBD-UHFFFAOYSA-N 0.000 description 1
- BABXJJMLNRMVEU-UHFFFAOYSA-N CCOC1=CC=C(CN(CC(c(cc2C(C)(C)C)cc(N3CCOCC3)c2OC)=O)C2=N)N2C1=O Chemical compound CCOC1=CC=C(CN(CC(c(cc2C(C)(C)C)cc(N3CCOCC3)c2OC)=O)C2=N)N2C1=O BABXJJMLNRMVEU-UHFFFAOYSA-N 0.000 description 1
- DTQVDTLACAAQTR-UHFFFAOYSA-N OC(C(F)(F)F)=O Chemical compound OC(C(F)(F)F)=O DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pulmonology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Hospice & Palliative Care (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Endocrinology (AREA)
- Pain & Pain Management (AREA)
- Vascular Medicine (AREA)
- Psychiatry (AREA)
- Emergency Medicine (AREA)
- Obesity (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102006036023.0 | 2006-08-02 | ||
| DE102006036023A DE102006036023A1 (de) | 2006-08-02 | 2006-08-02 | Imino-imidazo-pyridinderivate mit antithrombotischer Aktivität |
| PCT/EP2007/006360 WO2008014888A2 (de) | 2006-08-02 | 2007-07-18 | Imino-imidazo-pyridinderivate mit antithrombotischer aktivität |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101495478A CN101495478A (zh) | 2009-07-29 |
| CN101495478B true CN101495478B (zh) | 2013-03-27 |
Family
ID=38884850
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2007800279925A Expired - Fee Related CN101495478B (zh) | 2006-08-02 | 2007-07-18 | 具有抗血栓形成活性的亚氨基-咪唑并-吡啶衍生物 |
Country Status (23)
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY152040A (en) * | 2008-02-05 | 2014-08-15 | Sanofi Aventis | Triazolopyridazines as par1 inhibitors, production thereof, and use as medicaments |
| KR20150122786A (ko) | 2013-03-15 | 2015-11-02 | 펀다시오 인스티튜트 드 르세르카 바이오메디카 (아이알비 바르셀로나) | 암 전이의 진단, 예후 및 치료를 위한 방법 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1391451A1 (en) * | 2001-04-19 | 2004-02-25 | Eisai Co., Ltd. | 2-iminopyrrolidine derivates |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5124517B1 (cg-RX-API-DMAC7.html) | 1971-03-15 | 1976-07-24 | ||
| DE2221796A1 (de) | 1972-05-04 | 1973-11-15 | Kraemer Kg Wilhelm | Batteriebehaelter fuer stabbatterien |
| JPS60161986A (ja) * | 1983-12-24 | 1985-08-23 | Nippon Soda Co Ltd | イミダゾ(1,5−a)ピリジン−3−オン誘導体及びその製造方法 |
| US6063847A (en) | 1997-11-25 | 2000-05-16 | Schering Corporation | Thrombin receptor antagonists |
| US7488742B2 (en) | 2000-06-15 | 2009-02-10 | Schering Corporation | Thrombin receptor antagonists |
| EP1982984B1 (en) | 2002-04-16 | 2013-02-13 | Merck Sharp & Dohme Corp. | Manufacture of tricyclic thrombin receptor antagonists and pharmaceutical compositions comprising them |
| EP1602646A4 (en) | 2003-02-19 | 2010-07-28 | Eisai R&D Man Co Ltd | PROCESS FOR PREPARING CYCLIC BENZAMIDINE DERIVATIVES |
| DE10353205A1 (de) | 2003-11-13 | 2005-06-16 | Aventis Pharma Deutschland Gmbh | Ortho-substituierte Pentafluorsulfuranyl-Benzole, Verfahren zu ihrer Herstellung sowie ihre Verwendung als wertvolle Synthese-Zwischenstufen |
| US7317124B2 (en) | 2003-11-13 | 2008-01-08 | Sanofi-Aventis Deutschland Gmbh | Ortho-substituted pentafluorosulfanylbenzenes, process for their preparation and their use as valuable synthetic intermediates |
-
2006
- 2006-08-02 DE DE102006036023A patent/DE102006036023A1/de not_active Withdrawn
-
2007
- 2007-07-18 AU AU2007280780A patent/AU2007280780B2/en not_active Ceased
- 2007-07-18 PT PT07765222T patent/PT2054412E/pt unknown
- 2007-07-18 EP EP07765222A patent/EP2054412B1/de not_active Not-in-force
- 2007-07-18 MX MX2009000408A patent/MX2009000408A/es active IP Right Grant
- 2007-07-18 DK DK07765222.0T patent/DK2054412T3/da active
- 2007-07-18 DE DE502007002219T patent/DE502007002219D1/de active Active
- 2007-07-18 WO PCT/EP2007/006360 patent/WO2008014888A2/de not_active Ceased
- 2007-07-18 ES ES07765222T patent/ES2336044T3/es active Active
- 2007-07-18 KR KR1020097002137A patent/KR20090129981A/ko not_active Abandoned
- 2007-07-18 CN CN2007800279925A patent/CN101495478B/zh not_active Expired - Fee Related
- 2007-07-18 CA CA2663332A patent/CA2663332C/en not_active Expired - Fee Related
- 2007-07-18 AT AT07765222T patent/ATE450537T1/de active
- 2007-07-18 MY MYPI20090170A patent/MY148611A/en unknown
- 2007-07-18 JP JP2009522134A patent/JP5149897B2/ja not_active Expired - Fee Related
- 2007-07-18 BR BRPI0714599-3A patent/BRPI0714599A2/pt not_active IP Right Cessation
- 2007-07-31 PE PE2007000991A patent/PE20080687A1/es not_active Application Discontinuation
- 2007-07-31 TW TW096127870A patent/TWI400240B/zh not_active IP Right Cessation
- 2007-07-31 AR ARP070103373A patent/AR062158A1/es not_active Application Discontinuation
- 2007-07-31 DO DO2007000120A patent/DOP2007000120A/es unknown
- 2007-08-01 CL CL200702240A patent/CL2007002240A1/es unknown
-
2009
- 2009-01-29 IL IL196789A patent/IL196789A/en not_active IP Right Cessation
- 2009-02-02 US US12/364,124 patent/US7863269B2/en not_active Expired - Fee Related
- 2009-02-16 NO NO20090741A patent/NO20090741L/no not_active Application Discontinuation
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1391451A1 (en) * | 2001-04-19 | 2004-02-25 | Eisai Co., Ltd. | 2-iminopyrrolidine derivates |
| EP1391456A1 (en) * | 2001-04-19 | 2004-02-25 | Eisai Co., Ltd. | 2-iminoimidazole derivative (2) |
Also Published As
| Publication number | Publication date |
|---|---|
| KR20090129981A (ko) | 2009-12-17 |
| US7863269B2 (en) | 2011-01-04 |
| PT2054412E (pt) | 2010-02-04 |
| CN101495478A (zh) | 2009-07-29 |
| DK2054412T3 (da) | 2010-04-19 |
| NO20090741L (no) | 2009-02-16 |
| WO2008014888A3 (de) | 2008-06-12 |
| DE102006036023A1 (de) | 2008-02-07 |
| TWI400240B (zh) | 2013-07-01 |
| US20090192150A1 (en) | 2009-07-30 |
| ES2336044T3 (es) | 2010-04-07 |
| JP2009545542A (ja) | 2009-12-24 |
| DE502007002219D1 (de) | 2010-01-14 |
| TW200821308A (en) | 2008-05-16 |
| JP5149897B2 (ja) | 2013-02-20 |
| EP2054412A2 (de) | 2009-05-06 |
| MY148611A (en) | 2013-05-15 |
| AR062158A1 (es) | 2008-10-22 |
| MX2009000408A (es) | 2009-01-27 |
| AU2007280780A1 (en) | 2008-02-07 |
| HK1135694A1 (en) | 2010-06-11 |
| IL196789A0 (en) | 2009-11-18 |
| IL196789A (en) | 2012-07-31 |
| PE20080687A1 (es) | 2008-07-24 |
| CA2663332A1 (en) | 2008-02-07 |
| CA2663332C (en) | 2015-06-02 |
| AU2007280780B2 (en) | 2012-03-29 |
| BRPI0714599A2 (pt) | 2013-04-09 |
| WO2008014888A2 (de) | 2008-02-07 |
| ATE450537T1 (de) | 2009-12-15 |
| CL2007002240A1 (es) | 2008-02-08 |
| DOP2007000120A (es) | 2008-02-29 |
| EP2054412B1 (de) | 2009-12-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4316794B2 (ja) | イソキノリン誘導体及び医薬 | |
| CN101460499A (zh) | 可用作janus激酶抑制剂的去氮杂嘌呤 | |
| JP2000517301A (ja) | テトラヒドロイソキノリン誘導体およびそれらの薬理学的使用 | |
| CN102083826A (zh) | 磷脂酰肌醇3-激酶的抑制剂 | |
| CN101516834A (zh) | 用作凝血因子IXa抑制剂的异丝氨酸衍生物 | |
| WO2012174856A1 (zh) | 一类可用于口服的凝血酶抑制剂及其制法以及医药用途 | |
| CN101981035A (zh) | 作为par1抑制剂的三唑盐、其制备及其作为药物的用途 | |
| CN101516833B (zh) | 用作凝血因子IXa抑制剂的酒石酸衍生物 | |
| WO2024040768A1 (zh) | 5-吡啶-1h-吲唑类化合物、药物组合物和应用 | |
| CN101980710A (zh) | 作为par1抑制剂的咪唑并哒嗪、其制备及其作为药物的用途 | |
| CN101495478A (zh) | 具有抗血栓形成活性的亚氨基-咪唑并-吡啶衍生物 | |
| KR20230022861A (ko) | Tead 결합제로서 유용한 트리시클릭 헤테로사이클 | |
| JP2021521132A (ja) | 置換オキソピリジン誘導体 | |
| CN101006059A (zh) | 以mmp抑制剂形式使用的被取代的四氢异喹啉、其制备方法和其以药物形式的应用 | |
| CN109890809A (zh) | 作为pfkfb的抑制剂的取代的喹喔啉衍生物 | |
| CZ20011216A3 (cs) | Benzamidové deriváty | |
| HK1135694B (en) | Imino-imidazo-pyridine derivatives having antithrombotic activity | |
| CN118993944A (zh) | 胍基取代的芳香酯类衍生物、其制备方法及在医药上的应用 | |
| TW200401771A (en) | Novel compound |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1135694 Country of ref document: HK |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: GR Ref document number: 1135694 Country of ref document: HK |
|
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20130327 Termination date: 20180718 |